Treating high-risk, asymptomatic bone metastases with radiation may reduce pain, extend survival

Treating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and hospitalizations and possibly extend overall survival in people whose cancer has spread to multiple sites, a phase II clinical trial suggests.

Related Keywords

New York ,United States ,Memorial Sloan Kettering Cancer Center ,Erinf Gillespie ,Emily Henderson ,American Society For Radiation Oncology ,Lab Diagnostics Automation ,Lab Diagnostics Automation Industry ,American Society ,Radiation Oncology ,Lead Author ,Radiation Oncologist ,Automation Industry Focus ,Bone ,Rain ,Radiation Therapy ,Dancer ,Clinical Trial ,Health Care ,Ncology ,Pine ,